knowledge -WSS

knowledge

author：Wikipedia 2025-09-28 23:11:34 - browse：22551

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

Advisers to the Food and Drug Administration voted 11-0 on Monday to recommend the approval of a drug for early Alzheimer’s disease made by Eli Lilly — ruling that the treatment’s ability to slow the cognitive decline in patients outweighed its safety risks.

The unanimous outcome of the daylong advisory panel was the best-case scenario for Lilly, making it likely that the FDA will approve the drug, called donanemab, for a broad population of people diagnosed with mild cognitive impairment due to Alzheimer’s. A decision is expected later this year.

“The benefits outweigh the risks, as long as the risks are being monitored,” said Kathleen Poston, a neurologist at Stanford University and a member of the advisory panel.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Tuskegee Airman Raymond Cassagnol dies at 102

focus

WSS

Supreme Court rules employers must be more accommodating of religious observance

Intellia plays down concerns on accidental germline transmission

What Wagner Group's armed rebellion could mean for Russia's endgame in Ukraine

Meadows told special counsel he could not recall Trump ever declassifying Mar

Hospital at home shows how to bring innovation to health care

Newly formed Hurricane Beatriz sweeps close to Mexico's southwest Pacific coast

entertainment

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

focus

Apple is now the first public company to be valued at $3 trillion

Wegovy improves function in certain heart failure patients

Apple is now the first public company to be valued at $3 trillion

National associations that represent hospice owe an apology

Affirmative action in medical school literally saved lives

People can get long Covid without testing positive for virus: Study

Guidelines to prevent youth baseball injuries need more muscle

Lilly’s obesity pill cuts 15% of weight at highest dose in mid

New air purifier tech could be key to improving indoor air quality

Meadows told special counsel he could not recall Trump ever declassifying Mar

explore

California store owner shot dead in dispute over displaying Pride flag: Police

GOP inquiry over gain

Why do we get seasonal allergies?

Roche's accidental data boosts hopes for anti

As obesity drug market grows, telehealth companies court payers

How the drug

focus

hotspot

focus

Wikipedia